Published in Blood Weekly, January 14th, 2010
"This trial represents a major milestone in developing a therapy aimed at curing sickle cell disease," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.